Novo Nordisk A/S
NONOF
$136.96
-$1.03-0.75%
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3.21% | 0.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.21% | 0.07% | |||
| Cost of Revenue | 2.67% | -0.13% | |||
| Gross Profit | 3.30% | 0.11% | |||
| SG&A Expenses | 10.63% | -21.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -170.66% | 19,195.82% | |||
| Total Operating Expenses | 7.74% | -10.33% | |||
| Operating Income | -1.56% | 13.98% | |||
| Income Before Tax | -21.35% | 16.56% | |||
| Income Tax Expenses | -19.61% | 16.09% | |||
| Earnings from Continuing Operations | -21.80% | 16.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.80% | 16.68% | |||
| EBIT | -1.56% | 13.98% | |||
| EBITDA | -0.85% | 18.30% | |||
| EPS Basic | -21.76% | 16.80% | |||
| Normalized Basic EPS | -3.61% | 11.14% | |||
| EPS Diluted | -21.66% | 16.71% | |||
| Normalized Diluted EPS | -3.54% | 11.19% | |||
| Average Basic Shares Outstanding | -0.04% | -0.11% | |||
| Average Diluted Shares Outstanding | -0.11% | -0.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -1.00% | -- | |||
